Lycopene in Treating Patients Undergoing Radical Prostatectomy for Prostate Cancer

Major Program
Phase 0 I II Cancer Prevention Clinical Trials Program
Research Group
Prostate and Urologic Cancer
Sponsor
National Cancer Institute (NCI)
Status
Completed
ClinicalTrials.gov ID
For more information, see ClinicalTrials.gov NCT00450749
This randomized phase II trial studies how well different doses of lycopene work in treating patients undergoing radical prostatectomy for prostate cancer. The use of lycopene, a substance found in tomatoes, may keep prostate cancer from growing or coming back after surgery.
Intervention
placebo, therapeutic conventional surgery, laboratory biomarker analysis, lycopene
Condition
Adenocarcinoma of the Prostate, Stage I Prostate Cancer, Stage II Prostate Cancer, Stage III Prostate Cancer
Investigators
James Eastham

See list of participating sites